{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T06:09:55Z","timestamp":1788934195374,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oral Maxillofac Surg"],"DOI":"10.1007\/s10006-024-01316-0","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T10:13:37Z","timestamp":1736417617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Survival benefit of cancer-directed surgery and the role of adjuvant therapy in malignant major salivary gland cancers: a propensity score matched retrospective analysis"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0965-7550","authenticated-orcid":false,"given":"Ahmed","family":"Elkoumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Elkoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Hamouda","family":"Elkasaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huzifa","family":"Khitiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam Khaled","family":"Elbairy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar K.","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9025-3885","authenticated-orcid":false,"given":"Abeer","family":"Shaalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"issue":"17","key":"1316_CR1","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1200\/JCO.2005.05.3025","volume":"24","author":"SA Laurie","year":"2006","unstructured":"Laurie SA, Licitra L (2006) Systemic therapy in the palliative management of advanced salivary gland cancers. J Clin Oncol 24(17):2673\u20132678. https:\/\/doi.org\/10.1200\/JCO.2005.05.3025","journal-title":"J Clin Oncol"},{"key":"1316_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.critrevonc.2009.10.004","volume":"74","author":"M Guzzo","year":"2010","unstructured":"Guzzo M, Locati LD, Prott FJ, Gatta G, Mcgurk M, Licitra L (2010) Major and minor salivary gland tumors. Crit Rev Oncol Hematol 74:134\u2013148","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3-4","key":"1316_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1615\/CritRevOncog.2018027598","volume":"23","author":"H Helen Lin","year":"2018","unstructured":"Helen Lin H, Limesand KH, Ann DK (2018) Current State of Knowledge on Salivary Gland Cancers. Crit Rev Oncog 23(3\u20134):139\u2013151. https:\/\/doi.org\/10.1615\/CritRevOncog.2018027598","journal-title":"Crit Rev Oncog"},{"issue":"2","key":"1316_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/hed.25499","volume":"41","author":"AV Mantravadi","year":"2019","unstructured":"Mantravadi AV, Moore MG, Rassekh CH (2019) AHNS series: Do you know your guidelines? Diagnosis and management of salivary gland tumors. Head Neck 41(2):269\u2013280","journal-title":"Head Neck"},{"key":"1316_CR5","unstructured":"Reeve BB, Smith AW, Arora NK, Hays RD Reducing Bias in Cancer Research: Application of Propensity Score Matching. Health Care Financ Rev [Internet]. 2008 Jun [cited 2024 Mar 24];29(4):69. Available https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4195028\/"},{"key":"1316_CR6","doi-asserted-by":"crossref","unstructured":"Yao XI, Wang X, Speicher PJ, Hwang ES, Cheng P, Harpole DH et al Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies. JNCI Journal of the National Cancer Institute [Internet]. 2017 Aug 1 [cited 2024 Mar 24];109(8). Available https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6059208\/","DOI":"10.1093\/jnci\/djw323"},{"issue":"3","key":"1316_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/hed.2890080309","volume":"8","author":"RH Spiro","year":"1986","unstructured":"Spiro RH (1986) Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 8(3):177\u2013184. https:\/\/doi.org\/10.1002\/hed.2890080309","journal-title":"Head Neck Surg"},{"issue":"4","key":"1316_CR8","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/annonc\/mdx771","volume":"29","author":"C Fushimi","year":"2018","unstructured":"Fushimi C, Tada Y, Takahashi H, Nagao T, Ojiri H, Masubuchi T et al (2018) A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma. Ann Oncol 29(4):979\u2013984. https:\/\/doi.org\/10.1093\/annonc\/mdx771","journal-title":"Ann Oncol"},{"issue":"17","key":"1316_CR9","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1200\/JCO.21.00449","volume":"39","author":"JL Geiger","year":"2021","unstructured":"Geiger JL, Ismaila N, Beadle B, Caudell JJ, Chau N, Deschler D et al (2021) Management of Salivary Gland Malignancy: ASCO Guideline. J Clin Oncol 39(17):1909\u20131941. https:\/\/doi.org\/10.1200\/JCO.21.00449","journal-title":"J Clin Oncol"},{"key":"1316_CR10","doi-asserted-by":"crossref","unstructured":"van Herpen C, Vander Poorten V, Skalova A, Terhaard C, Maroldi R, van Engen A et al Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open [Internet]. 2022 Dec 1 [cited 2024 Apr 18];7(6). https:\/\/pubmed.ncbi.nlm.nih.gov\/36567082\/","DOI":"10.1016\/j.esmoop.2022.100602"},{"issue":"2","key":"1316_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.critrevonc.2014.02.002","volume":"91","author":"T Cerda","year":"2014","unstructured":"Cerda T, Sun XS, Vignot S, Marcy PY, Baujat B, Baglin AC et al (2014) A rationale for chemoradiation (vs radiotherapy) in salivary gland cancers? On behalf of the REFCOR (French rare head and neck cancer network). Crit Rev Oncol Hematol 91(2):142\u2013158","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"1316_CR12","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/hed.24984","volume":"40","author":"S Cheraghlou","year":"2018","unstructured":"Cheraghlou S, Kuo P, Mehra S, Agogo GO, Bhatia A, Husain ZA et al (2018) Adjuvant therapy in major salivary gland cancers: Analysis of 8580 patients in the National Cancer Database. Head Neck 40(7):1343\u20131355. https:\/\/doi.org\/10.1002\/hed.24984","journal-title":"Head Neck"},{"issue":"1","key":"1316_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-25468-9","volume":"12","author":"NW Kang","year":"2022","unstructured":"Kang NW, Kuo YH, Wu HC, Ho CH, Chen YC, Yang CC (2022) No survival benefit from adding chemotherapy to adjuvant radiation in advanced major salivary gland cancer. Scientific Reports 12(1):1\u201310. https:\/\/doi.org\/10.1038\/s41598-022-25468-9","journal-title":"Scientific Reports"},{"issue":"1","key":"1316_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/hed.27222","volume":"45","author":"AJ Gordon","year":"2023","unstructured":"Gordon AJ, Chow MS, Patel A, Hu KS, Li Z, Jacobson AS et al (2023) Adoption of adjuvant chemotherapy in high-risk salivary gland malignancies. Head Neck 45(1):167\u2013177. https:\/\/doi.org\/10.1002\/hed.27222","journal-title":"Head Neck"},{"issue":"11","key":"1316_CR15","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/hed.24484","volume":"38","author":"MJ Mifsud","year":"2016","unstructured":"Mifsud MJ, Tanvetyanon T, Mccaffrey JC, Otto KJ, Padhya TA, Kish J et al (2016) Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomas. Head Neck 38(11):1628\u20131633. https:\/\/doi.org\/10.1002\/hed.24484","journal-title":"Head Neck"}],"container-title":["Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-024-01316-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10006-024-01316-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-024-01316-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T02:12:22Z","timestamp":1765159942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10006-024-01316-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1316"],"URL":"https:\/\/doi.org\/10.1007\/s10006-024-01316-0","relation":{},"ISSN":["1865-1569"],"issn-type":[{"value":"1865-1569","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since the SEER database is publicly available, ethical approval is not needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}